Dose-escalating study of vandetanib in volunteers

Trial Profile

Dose-escalating study of vandetanib in volunteers

Phase of Trial: Phase I

Latest Information Update: 12 Jan 2012

At a glance

  • Drugs Vandetanib (Primary)
  • Indications Biliary cancer; Breast cancer; Prostate cancer; Thyroid cancer
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 12 Jan 2012 New trial record
    • 27 Dec 2011 Results published in Clinical Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top